(1)
Rituximab in the Treatment of Refractory Myasthenia Gravis: Studying the Outcomes Using MMT Score And Need for Plasmapheresis in Baghdad Teaching Hospital. Indian Journal of Forensic Medicine & Toxicology 2020, 14 (2), 2505-2510. https://doi.org/10.37506/ijfmt.v14i2.3485.